Visfatin level in hypertensive patients with abdominal obesity against the combination of anti-hypertensive therapy and atorvastatin

dc.contributor.authorAndrieieva, Anastasiia
dc.date.accessioned2014-11-27T07:45:31Z
dc.date.available2014-11-27T07:45:31Z
dc.date.issued2014-09
dc.description.abstractThe treatment of hypertensive patients with abdominal obesity and dyslipidemia considering the dynamics of the visfatin level in the blood serum receiving combination of anti-hypertensive therapy and atorvastatin is relevant.uk_UA
dc.identifier.citationAndrieieva A. Visfatin level in hypertensive patients with abdominal obesity against the combination of anti-hypertensive therapy and atorvastatin / A. Andrieieva // Prague European Days of Internal Medicine, Prague, Czech Republic, 18–20 September, 2014 : abstracts. – 2014. – P. 17.uk_UA
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/8037
dc.language.isoenuk_UA
dc.subjectvisfatinuk_UA
dc.subjectarterial hypertensionuk_UA
dc.subjectabdominal obesityuk_UA
dc.subjectanti-hypertensive therapyuk_UA
dc.subjectatorvastatinuk_UA
dc.titleVisfatin level in hypertensive patients with abdominal obesity against the combination of anti-hypertensive therapy and atorvastatinuk_UA
dc.typeThesisuk_UA

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
AndrieievaA.pdf
Size:
154.33 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.52 KB
Format:
Item-specific license agreed upon to submission
Description: